- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Analyst Shares Top Picks In Biotechnology Sector With CNBC (AMGN, ACOR, DNDN, GILD)
Recent Articles by Ed Liston
- Regulators Failed During The Financial Crisis Due To Complacency; Alan Greenspan (JPM)
- Court Asks Fed To Disclose Records Of $2 Trillion U.S. Loan Program Launched After Lehman Collapse (OPY)
- Boeing (BA) Plans To Raise Production Of 777s And 747s Sooner-Than-Expected
- Metabolix, Inc. (MBLX) Maintains Market Weight Rating
- Pressure Mounts On EU To Create A System To Handle Failure Of Large Banks
CNBC
- General Growth Properties (GGP) Is Back In Favor
- Jim Cramer's Lightning Round Picks (APD, WEN, MCD, TSRA, VSI, VITC, PTV, IP, STXS, ABT, NMM, ATPG, GMCR)
- Fast Money Picks For March 22nd (MHS, CVS)
- Cramer Recommends Sonus Networks As A Speculative Play (SONS)
- Guy Adami Likes TIF
Media
- Jim Cramer's Lightning Round Picks (APD, WEN, MCD, TSRA, VSI, VITC, PTV, IP, STXS, ABT, NMM, ATPG, GMCR)
- Fast Money Picks For March 22nd (MHS, CVS)
- Pressure Mounts On EU To Create A System To Handle Failure Of Large Banks
- Lowe’s (LOW) Could See Faster Growth Than Rival; Barron’s
- Dr Pepper (DPS) Pouring Out Sweet Returns For Investors; Barron’s
Posted on 02/09/10 at 9:13am by Ed Liston
Biotechnology stocks have performed well so far this year. Mark Schoebebaum, managing director and senior research analyst at Deutsche Bank (NYSE: DB), shared his views about the sector with CNBC.
According to Schoebebaum, the sector performed extremely well during the tough times in 2008. However, 2009 saw a tepid performance due to the pending health care bill. According to Schoebebaum, biotechnology drugs are high-price drugs, and the price points look less sustainable in the light of health care bill provisions.
Among the companies in the sector, Schoenebaum likes Amgen (NASDAQ: AMGN), Gilead Sciences (NASDAQ: GILD), Acorda Therapeutics (NASDAQ: ACOR) and Dendreon(NASDAQ: DNDN).
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
